GleamWall
中文EN

STXS Stereotaxis, Inc.

Electromedical & Electrotherapeutic Apparatus · NYSE · SEC CIK 1289340 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY4.8%
TTM net income YoY5.4%
TTM EPS YoY14.3%
Revenue 3-yr CAGR2.2%
Net income 3-yr CAGR—

Margins

Gross margin52.5%
Operating margin-71.9%
Net margin-70.9%
FCF margin-49.2%
EBITDA margin-69.6%

Returns

ROE-161.7%
ROA-35.0%
ROIC (approx.)-229.4%
Asset turnover0.49x

Leverage & solvency

Liabilities / assets67.7%
Debt / equity0.12x
Current ratio1.08x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.68x
Accruals ratio-11.1%
Payout ratio—
Capex / revenue0.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$8.93M$7.67M$6.29M$8.64M$7.46M$8.80M$7.47M$6.34M
Cost of revenue$4.97M$3.18M$2.50M$4.32M$3.36M$4.22M$3.41M$3.12M
Gross profit$3.96M$4.49M$3.79M$4.33M$4.10M$4.58M$4.06M$3.22M
R&D expense$3.52M$2.39M$2.40M$2.71M$2.55M$1.78M$2.35M$2.79M
SG&A expense$4.05M$4.07M$4.76M$4.17M$5.18M$4.00M$4.50M$5.14M
Operating income-$6.47M-$4.57M-$5.98M-$5.65M-$6.56M-$3.98M-$5.93M-$7.63M
Interest expense$44,000———————
Net income-$6.48M-$4.47M-$5.86M-$5.53M-$6.46M-$3.83M-$5.82M-$7.51M
EBITDA-$6.24M-$4.40M-$5.82M-$5.49M-$6.40M-$3.82M-$5.77M-$7.47M
EPS (basic)-0.07-0.05-0.06—-0.07-0.05-0.07—
EPS (diluted)-0.07-0.05-0.06—-0.07-0.05-0.07—
Weighted avg. shares (diluted)102.55M100.03M98.89M—92.01M87.95M87.77M—
Banking
Net interest income$75,000$100,000$125,000$118,000$91,000$152,000$106,000$114,000
Balance sheet
Cash & equivalents$3.98M$10.49M$14.62M$13.42M$10.51M$6.97M$10.60M$12.22M
Short-term investments$0$0—$0$0——$0
Receivables$5.58M$7.55M$5.30M$5.85M$5.33M$4.39M$4.32M$3.82M
Inventory$13.27M$12.52M$10.49M$9.57M$10.15M$9.61M$9.81M$8.33M
Current assets$34.44M$37.99M$36.03M$33.85M$26.66M$21.90M$25.91M$26.44M
PP&E, net$4.12M$2.88M$2.96M$3.02M$3.16M$3.28M$3.44M$3.57M
Goodwill$29.28M$3.76M$3.76M$3.76M$3.76M$3.76M$3.76M$3.76M
Intangibles$6.99M$5.96M$6.19M$6.43M$6.67M$6.90M$7.14M$7.36M
Total assets$82.11M$55.58M$54.03M$52.25M$45.59M$41.17M$45.70M$46.72M
Current liabilities$31.76M$26.80M$23.09M$22.36M$20.37M$20.75M$24.23M$21.60M
Short-term debt$548,000———————
Long-term debt$1.92M———————
Total debt$2.47M———————
Total liabilities$55.58M$38.10M$34.43M$33.53M$34.05M$34.42M$37.53M$35.29M
Shareholders' equity$21.36M$12.24M$14.36M$13.48M$6.27M$1.46M$2.88M$6.08M
Net debt-$1.51M———————
Cash flow statement
Operating cash flow-$4.18M-$3.67M-$3.44M-$3.97M-$4.20M-$3.73M-$1.78M$1.27M
Capital expenditure$27,000$64,000$79,000$70,000$0——$2,000
Free cash flow-$4.20M-$3.74M-$3.52M-$4.04M-$4.20M——$1.26M
Investing cash flow-$2.95M-$1.15M-$79,000-$70,000$0——-$2,000
Financing cash flow$614,000$695,000$4.72M$6.95M$7.74M$34,000$32,000$159,000
Depreciation & amortization$230,000$171,000$159,000$158,000$156,000$156,000$156,000$159,000
Stock-based compensation$1.69M$1.61M$2.11M$2.45M$2.50M$2.37M$2.54M$2.57M
Dividends paid$0$0$0$0$0$0$0$0

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.